Dr. Abdel-Massih's research interests include infectious complications in transplant recipients, cytomegalovirus, fungal infections and bacterial resistance. She is a co-investigator on multiple clinical trials. She also has a special interest in telehealth models of care applied in the infectious diseases specialty.
Dr. Rima Adbel-Massih, is an Assistant Professor of Medicine in the Division of Infectious Diseases. She joined the Transplant Infectious Diseases group upon completion of a transplant infectious diseases Fellowship at Mayo Clinic. Her major clinical interest are in the field of infections in solid organ transplant recipients as well as infections related to artificial heart and lung devices. Dr. Abdel-Massih is a member of the Antimicrobial Management Program and Director of Education for the Division of Transplant Infectious Diseases. Dr. Abdel-Massih also has interest in developing and instituting models of telemedicine service in infectious diseases.
Dr. Abdel-Massih is the Transplant Infectious Diseases Education and Fellowship Director. In 2013, she was appointed Associate Program Director for the General Infectious Diseases Fellowship. She mentors infectious diseases fellows in their training and helps them maximize their educational experience by individualizing their second year of training based upon their career path and interests.
- MD, Lebanese University, Beirut, Lebanon, 2001
- Residency, Internal Medicine, Seton Hall University, 2006
- Associate Chief Resident, Seton Hall University, 2006
- Fellowship, Infectious Diseases, Seton Hall University, 2008
- Fellowship, Transplant Infectious Disease, Mayo Clinic, 2009
Education & Training
Silveira FP, Abdel-Massih R, Bogdanovich T, Pakstis DL, Routh RL, Moss RB. Treatment of resistant influenza virus infection in a hospitalized patient with cystic fibrosis with DAS181, a host-directed antiviral. Antiviral Therapy. 2016; 21(1): 71-4.
Cariello PF, Kwak EJ, Abdel-Massih RC, Silveira FP. Safety and tolerability of clofazimine as salvage therapy for atypical mycobacterial infection in solid organ transplant recipients. Transpl Infect Dis. 2015; 17(1): 111-8.
Eschenauer GA, Kwak EJ, Humar A, Potoski BA, Clarke LG, Shields RK, Abdel-Massih R, Silveira FP, Vergidis P, Clancy CJ, Nguyen MH. Targeted versus universal antifungal prophylaxis among liver transplant recipients. Am J Transplant. 2015; 15(1): 180-9.
Baydoun E, Karam M, Atia-tul-Wahab, Khan MS, Ahmad MS, Samreen, Smith C, Abdel-Massih R, Choudhary MI. Microbial transformation of nandrolone with Cunninghamella echinulata and Cunninghamella blakesleeana and evaluation of leishmaniacidal activity of transformed products. Steroids. 2014 Oct;88:95-100. PMID: 25014252.
Clancy CJ, Chen L, Shields RK, Zhao Y, Cheng S, Chavda KD, Hao B, Hong JH, Doi Y, Kwak EJ, Silveira FP, Abdel-Massih R, Bogdanovich T, Humar A, Perlin DS, Kreiswirth BN, Hong Nguyen M. Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients. Am J Transplant. 2013; 13(10): 2619-33.
- Associate Program Director of the Infectious Diseases Fellowship, 2013
